Molecular imaging with contrast ultrasound and targeted microbubbles

From Bench to Imaging


There is growing interest in the development of methods for imaging cellular and molecular mediators of cardiovascular diseases. Techniques for imaging molecular and cellular alterations have been explored for essentially all noninvasive cardiac imaging modalities. Molecular imaging with contrast-enhanced ultrasound relies on the detection of novel site-targeted microbubble contrast agents. These microbubbles are retained within regions of a specific disease process, thereby allowing phenotypic characterization of tissue. As microbubbles are pure intravascular tracers, the disease processes assessed must be characterized by antigens that are expressed within the vascular compartment. Accordingly, the pathologic states that have been targeted include inflammation, neoplasms, angiogenesis, and thrombus formation, all of which are mediated in part by molecular events within the vascular space. This review describes (1) different strategies that have been used to target microbubbles to regions of disease, (2) the unique challenges for imaging targeted ultrasound contrast agents, and (3) some of the early experience imaging molecular events in animal models of disease.


  1. 1.
    Lindner JR, Coggins MP, Kaul S, et al. Microbubble persistence in the microcirculation during ischemia-reperfusion and inflammation: integrin- and complement-mediated adherence to activated leukocytes. Circulation 2000;101:668–75.CrossRefPubMedGoogle Scholar
  2. 2.
    Klibanov AL. Targeted delivery of gas-filled microspheres, contrast agents for ultrasound imaging. Adv Drug Deliv Rev 1999;37: 139–57.CrossRefPubMedGoogle Scholar
  3. 3.
    Dayton PA, Pearson D, Clark J,et al. Ultrasonic enhancement of αvβ3-expressing cells with targeted contrast agents. Proc IEEE Ultrasonics Symposium; October 5–8, 2003.Google Scholar
  4. 4.
    Lindner JR, Song J, Xu F, et al. Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes. Circulation 2000;102:2745–50.CrossRefPubMedGoogle Scholar
  5. 5.
    Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425–34.CrossRefPubMedGoogle Scholar
  6. 6.
    Ley K. Molecular mechanisms of leukocyte recruitment in the inflammatory process. Cardiovasc Res 1996;32:733–42.CrossRefPubMedGoogle Scholar
  7. 7.
    Jung U, Norman KE, Scharffetter-Kochanek K, Beaudet AL, Ley K. Transit time of leukocytes rolling through venules controls cytokine-induced inflammatory cell recruitment in vivo. J Clin Invest 1998;102:1526–33.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Lindner JR, Dayton PA, Coggins MP, et al. Non-invasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles. Circulation 2000;102:531–8.CrossRefPubMedGoogle Scholar
  9. 9.
    Dayton PA, Chomas JE, Lum A, et al. Optical and acoustical dynamics of microbubble contrast agents inside neutrophils. Biophys J 2001;80:1547–56.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Christiansen JP, Leong-Poi H, Xu F, et al. Non-invasive imaging of myocardial reperfusion injury using leukocyte-targeted contrast echocardiography. Circulation 2002;105:1764–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Lindner JR, Song J, Christiansen J, et al. Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation 2001;104:2107–12.CrossRefPubMedGoogle Scholar
  12. 12.
    Villanueva FS, Jankowski RJ, Klibanov S, et al.Microbubbles targeted to intercellular adhesion molecule-I bind to activated coronary endothelial cells. Circulation 1998;98:1–5.CrossRefPubMedGoogle Scholar
  13. 13.
    Davis C, Christiansen JP, Klibanov AL, et al.Microbubbles targeted to endothelial VCAM-1 adhere to atherosclerotic plaques at physiologic shear rates [abstract]. Circulation 2003;108(Suppl):IV-624.Google Scholar
  14. 14.
    Nakashima Y, Raines EW, Plump AS, Breslow JL, Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol 1998;18:842–51.CrossRefPubMedGoogle Scholar
  15. 15.
    Alkan-Onyuksel H, Demos S, Lanza G, et al.Development of inherently echogenic liposomes as an ultrasonic contrast agent. J Pharm Sci 1996;85:486–90.CrossRefPubMedGoogle Scholar
  16. 16.
    Demos SM, Alkan-Onyuksel H, Kane BJ, et al.In vivo targeting of acoustically reflective liposomes for intravascular and transvalvular ultrasonic enhancement. J Am Coll Cardiol 1999;33:867–75.CrossRefPubMedGoogle Scholar
  17. 17.
    Weller GER, Lu E, Csikari MM, et al.Ultrasound imaging of acute cardiac transplant rejection with microbubbles targeted to intercellular adhesion molecule-1. Circulation 2003;108:218–24.CrossRefPubMedGoogle Scholar
  18. 18.
    Folkman J, Watson K, Ingber D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989;339:58–61.CrossRefPubMedGoogle Scholar
  19. 19.
    Moulton KS, Vakili K, Zurakowski D, et al.Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci U S A 2003;100:4736–41.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Leong-Poi H, Christiansen J, Klibanov AL, Kaul S, Lindner JR. Non-invasive assessment of angiogenesis by ultrasound and microbubbles targeted to αv-integrins. Circulation 2003;107:455–60.CrossRefPubMedGoogle Scholar
  21. 21.
    Ellegala DB, Leong-Poi H, Carpenter JE, et al.Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to αvβ3. Circulation 2003;108:336–41.CrossRefPubMedGoogle Scholar
  22. 22.
    Francis CW, Onundarson PT, Carstensen EL, Blinc A, Meltzer RS. Enhancement of fibrinolysis in vitro by ultrasound. J Clin Invest 1992;90:2063–8.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Tachibana K, Tachibana S. Albumin microbubble echo-contrast material as an enhancer for ultrasound accelerated thrombolysis. Circulation 1995;92:1148–50.CrossRefPubMedGoogle Scholar
  24. 24.
    Unger EC, McCreery TP, Sweitzer RH, Shen D, Wu G. In vitro studies of a new thrombus-specific ultrasound contrast agent. Am J Cardiol 1998;81:58G-61G.CrossRefPubMedGoogle Scholar
  25. 25.
    Lanza GM, Wallace KD, Scott MJ, et al.A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation 1997;95:3334–40.Google Scholar
  26. 26.
    Shohet RV, Chen S, Zhou Y, et al.Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation 2000;101:2554–6.CrossRefPubMedGoogle Scholar
  27. 27.
    Tamiyama Y, Tachibana K, Hiraoka K, et al.Local delivery of plasmid DNA into a rat carotid artery using ultrasound. Circulation 2002;105:1233–9.CrossRefGoogle Scholar
  28. 28.
    Christiansen JP, French BA, Klibanov AL, Kaul S, Lindner JR. Targeted tissue transfection with ultrasound destruction of plasmid- bearing cationic microbubbles. Ultrasound Med Biol 2003;29: 1759–67.CrossRefPubMedGoogle Scholar

Copyright information

© American Society of Nuclear Cardiology 2004

Authors and Affiliations

  1. 1.Cardiovascular DivisionUniversity of Virginia Medical CenterCharlottesville

Personalised recommendations